0.0012 Delayed Data As of Apr 18 | ![]() Today’s Change | 0.00 Today|||52-Week Range 0.02 | +27.78% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Rock Creek Pharmaceuticals Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +347,726.09% increase from the last price of 0.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.